<DOC>
	<DOC>NCT00584298</DOC>
	<brief_summary>This study is designed to provide information on feasibility and reproducibility of barostat assessments of colorectal sensory functions and compliance and their pharmacological modulation</brief_summary>
	<brief_title>Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Dilatation, Pathologic</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>A positive diagnosis of IBS. Subjects must either have been surgically sterilized, hysterectomized at least 6 months prior to screening, be postmenopausal or be using a doublebarrier local contraception. Able to communicate well with the investigator, to understand and comply with the requirements of the study. Understand and sign the written informed consent History of or evidence for structural diseases/conditions that affect the gastrointestinal system. Other diseases or conditions that in the opinion of the Investigator significantly affect colorectal sensitivity. Evidence of occult blood at stool analysis, or history of rectal bleeding. Using or planning to use drugs or agents during the study period that alter GI physiology and visceral perception.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Barostat</keyword>
	<keyword>distention</keyword>
	<keyword>IBS</keyword>
	<keyword>irritable</keyword>
	<keyword>bowel</keyword>
	<keyword>syndrome</keyword>
	<keyword>colorectal</keyword>
	<keyword>sensation</keyword>
	<keyword>modulation</keyword>
	<keyword>reproducibility</keyword>
</DOC>